Bal Pharma Q4 Results
- BSE: 524824
- NSE: BALPHARMA
- ISIN: INE083D01012
- Sector: Biotechnology & Drugs
BSE
133.2
-2.70 (-1.99%)
-2.70 (-1.99%)Volume631.00
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
134.4-2.75 (-2.01%)
-2.75 (-2.01%)Volume5.91 K
Updated: Mon 25 Nov, 2024 | 15:15:08
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Bal Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 94.63 | 76.62 | -% | 82.45 | -% |
| Selling/ General/ Admin Expenses Total | 15.64 | 14.06 | -% | 14.63 | -% |
| Depreciation/ Amortization | 2.16 | 2.45 | -% | 2.09 | -% |
| Other Operating Expenses Total | 15.63 | 11.53 | -% | 14.56 | -% |
| Total Operating Expense | 87.19 | 72.92 | -% | 76.37 | -% |
| Operating Income | 7.44 | 3.70 | -% | 6.08 | -% |
| Net Income Before Taxes | 5.75 | 1.05 | -% | 2.41 | -% |
| Net Income | 5.47 | 0.57 | -% | 1.60 | -% |
| Diluted Normalized EPS | 3.46 | 0.38 | -% | 0.93 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST